EU AI Act Readiness: A Structured Screening of 50 European AI Companies (April 2026) | Zenodo Skip to main Communities My dashboard Log in Sign up Sprinkling Act Research There is a newer version of the record available. Published April 2026 | Version v1 Report Open EU AI Act Readiness: A Structured Screening of 50 European AI Companies (April 2026) Authors/Creators Shucrani, Lamar B. (Researcher) 1 Show affiliations 1.
SprinklingAct Description Independent structured analysis of EU AI Act (Regulation (EU) 2024/1689) regulatory positioning across 50 European AI companies in HealthTech/MedTech, FinTech/InsurTech, HRTech/EdTech, and B2B SaaS/Industrial sectors, covering 15+ countries (FR, DE, BE, NL, PL, DK, CH, IE, UK, and others). Screening conducted between 10 and 12 April 2026. Each company was screened against a 6-gate regulatory framework mapping to Articles 5, 6(1), 6(2) + Annex III, 50, 51/53, and 6(3) of the Regulation. The screening relied exclusively on publicly available information (company websites, CE mark disclosures, ACPR/ECB/MDR/IVDR filings, LinkedIn, press releases). No company was contacted and no confidential data was accessed. The 6-gate framework used in this screening is publicly documented at sprinklingact.com/methodology. Key findings: 74% of screened companies trigger high-risk classification under Art. 6(1) or Art. 6(2) + Annex III 96% have no public AI Act regulatory position 44% have unaddressed Art. 50 transparency obligations 34% integrate GPAI models (Art. 3(63)) without documented Art. 50, Art. 26, or Art. 53 obligations 0 of 14 companies holding existing sectoral certifications (CE MDR, CE-IVD, ACPR banking licence) have mapped the additional AI Act layer 1 company raises an open question under Art. 5(1)(g) (biometric categorization in publicly accessible spaces) The report includes aggregate results, sector breakdowns, five anonymized critical cases, a deployer cascade analysis under Art. 26, an enforcement timeline (with Art. 6(2) + Annex III obligations becoming applicable on 2 August 2026), and the full methodology. Sprinkling Act operates as a pre-conformity advisory firm in this market; no commercial relationship with any company listed existed at the time of this analysis. This report is freely available to download, share, and reference with attribution. Notes (English) Analyst: Lamar B. Shucrani, Founder, SprinklingAct. Screening period: 10–12 April 2026. This report does not constitute legal advice. Only a personalised screening can confirm definitive regulatory status. Files eu-ai-act-readiness-report-april-2026.pdf Files (837.8 kB) Name Size Download all eu-ai-act-readiness-report-april-2026.pdf md5:a134924887bcf2450ebc30eb81850ad1 837.8 kB Preview Download Additional details Related works Is identical to Report: https://sprinklingact.com/reports/eu-ai-act-readiness-april-2026 (URL) Is part of Other: https://sprinklingact.com/reports (URL) References Other: https://sprinklingact.com/methodology (URL) Standard: http://data.europa.eu/eli/reg/2024/1689/oj (URL) Dates Collected 2026-04-10/ 2026-04-12 Screening period — data collection across 50 European AI companies Created 2026-04-12 Report finalized References Regulation (EU) 2024/1689 of the European Parliament and of the Council of 13 June 2024 laying down harmonised rules on artificial intelligence (Artificial Intelligence Act). OJ L, 2024/1689, 12.7.2024. ELI: http://data.europa.eu/eli/reg/2024/1689/oj Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC. OJ L 117, 5.5.2017. ELI: http://data.europa.eu/eli/reg/2017/745/oj Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU. OJ L 117, 5.5.2017. ELI: http://data.europa.eu/eli/reg/2017/746/oj Medical Device Coordination Group & Artificial Intelligence Board (2025). AIB 2025-1 / MDCG 2025-6 — Interplay between the Medical Devices Regulation (MDR) & In Vitro Diagnostic Medical Devices Regulation (IVDR) and the Artificial Intelligence Act (AIA). European Commission, 19 June 2025. Available at: https://health.ec.europa.eu/document/download/b78a17d7-e3cd-4943-851d-e02a2f22bbb4_en?filename=mdcg_2025-6_en.pdf 384 Views 129 Downloads Show more details All versions This version Views Total views 384 179 Downloads Total downloads 129 45 Data volume Total data volume 112.3 MB 49.4 MB More info on how stats are collected.... Versions External resources Indexed in OpenAIRE Communities Keywords and subjects Keywords EU AI Act, Regulation (EU) 2024/1689, AI regulation, AI compliance, AI governance, high-risk AI systems, Annex III, Article 5, Article 6, Article 50, Article 26, Article 53, GPAI, general-purpose AI, AI transparency, fundamental rights impact assessment, FRIA, HealthTech, MedTech, FinTech, InsurTech, HRTech, EdTech, SaaS, CE marking, MDR, IVDR, ACPR, European Union, regulatory readiness, pre-conformity, classification gap, 6-gate framework, AI Act screening, AI Act position, deployer obligations, Art. 6(1), Art. 6(2) Details DOI DOI Badge DOI 10.5281/zenodo.19671329 Markdown [](https://doi.org/10.5281/zenodo.19671329) reStructuredText .. image:: https://zenodo.org/badge/DOI/10.5281/zenodo.19671329.svg :target: https://doi.org/10.5281/zenodo.19671329 HTML <a href="https://doi.org/10.5281/zenodo.19671329"><img src="https://zenodo.org/badge/DOI/10.5281/zenodo.19671329.svg" alt="DOI"></a> Image URL https://zenodo.org/badge/DOI/10.5281/zenodo.19671329.svg Target URL https://doi.org/10.5281/zenodo.19671329 Resource type Report Publisher Zenodo Languages English Rights License Creative Commons Attribution 4.0 International The Creative Commons Attribution license allows re-distribution and re-use of a licensed work on the condition that the creator is appropriately credited. Read more Copyright Copyright © 2026 SprinklingAct. All rights reserved. Licensed under CC BY 4.0 for distribution and reuse with attribution. Citation Export Technical metadata Created April 20, 2026 Modified April 20, 2026 Jump up About About Policies Infrastructure Principles Projects Roadmap Contact Blog Blog Support Help FAQ Developers REST API OAI-PMH Contribute GitHub Donate Funded by Powered by CERN Data Centre & InvenioRDM Status Privacy policy Cookie policy Terms of Use This site uses cookies. Find out more on how we use cookies Accept all cookies Accept only essential cookies